These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30150431)

  • 1. Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation.
    Lee KC; Chen WT; Liu YC; Lin SS; Hsu FT
    In Vivo; 2018; 32(5):1097-1103. PubMed ID: 30150431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
    Weng MC; Wang MH; Tsai JJ; Kuo YC; Liu YC; Hsu FT; Wang HE
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29535278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma
    Lee KC; Tsai JJ; Tseng CW; Kuo YC; Chuang YC; Lin SS; Hsu FT
    In Vivo; 2018; 32(3):549-554. PubMed ID: 29695559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression
    Lee YJ; Chung JG; Chien YT; Lin SS; Hsu FT
    Anticancer Res; 2019 Jul; 39(7):3669-3675. PubMed ID: 31262893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma
    Tsai JJ; Hsu FT; Pan PJ; Chen CW; Kuo YC
    Anticancer Res; 2018 Apr; 38(4):2119-2125. PubMed ID: 29599330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
    Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
    Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
    Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
    Pan PJ; Tsai JJ; Liu YC
    Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
    Chen JC; Chuang HY; Hsu FT; Chen YC; Chien YC; Hwang JJ
    Oncotarget; 2016 Dec; 7(51):85450-85463. PubMed ID: 27863427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-
    Hsu FT; Chiang IT; Kuo YC; Hsia TC; Lin CC; Liu YC; Chung JG
    Am J Chin Med; 2019; 47(4):913-931. PubMed ID: 31096773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma
    Tsai JJ; Pan PJ; Hsu FT; Chung JG; Chiang IT
    Am J Chin Med; 2020; 48(1):223-244. PubMed ID: 32054305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
    Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
    In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
    Tsai JJ; Pan PJ; Hsu FT
    Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
    Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
    Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib.
    Yang CJ; Wu MH; Tsai JJ; Hsu FT; Hsia TC; Liu KC; Kuo YC
    Anticancer Res; 2022 May; 42(5):2495-2505. PubMed ID: 35489726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells.
    Chiang IT; Liu YC; Wang WH; Hsu FT; Chen HW; Lin WJ; Chang WY; Hwang JJ
    In Vivo; 2012; 26(4):671-81. PubMed ID: 22773582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.
    Wu CH; Hsu FT; Chao TL; Lee YH; Kuo YC
    Biomed Pharmacother; 2022 Jan; 145():112437. PubMed ID: 34864311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
    Huynh H; Ngo VC; Koong HN; Poon D; Choo SP; Toh HC; Thng CH; Chow P; Ong HS; Chung A; Goh BC; Smith PD; Soo KC
    J Hepatol; 2010 Jan; 52(1):79-87. PubMed ID: 19910069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amentoflavone reverses epithelial-mesenchymal transition in hepatocellular carcinoma cells by targeting p53 signalling pathway axis.
    Jian HY; Zhang JT; Liu Z; Zhang Z; Zeng PH
    J Cell Mol Med; 2024 Jun; 28(11):e18442. PubMed ID: 38842135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.